- Home
- TSHA vs CARE Comparison
TSHA vs CARE Comparison
Compare TSHA & CARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TSHA
- CARE
- Stock Information
- Founded
- TSHA 2019
- CARE 1974
- Country
- TSHA United States
- CARE United States
- Employees
- TSHA N/A
- CARE N/A
- Industry
- TSHA Biotechnology: Pharmaceutical Preparations
- CARE Major Banks
- Sector
- TSHA Health Care
- CARE Finance
- Exchange
- TSHA Nasdaq
- CARE Nasdaq
- Market Cap
- TSHA 397.8M
- CARE 330.3M
- IPO Year
- TSHA 2020
- CARE N/A
- Fundamental
- Price
- TSHA $2.71
- CARE $16.45
- Analyst Decision
- TSHA Strong Buy
- CARE Buy
- Analyst Count
- TSHA 7
- CARE 2
- Target Price
- TSHA $7.00
- CARE $21.50
- AVG Volume (30 Days)
- TSHA 5.2M
- CARE 67.8K
- Earning Date
- TSHA 05-15-2025
- CARE 07-24-2025
- Dividend Yield
- TSHA N/A
- CARE N/A
- EPS Growth
- TSHA N/A
- CARE 111.89
- EPS
- TSHA N/A
- CARE 1.20
- Revenue
- TSHA $7,224,000.00
- CARE $146,558,000.00
- Revenue This Year
- TSHA N/A
- CARE $10.63
- Revenue Next Year
- TSHA N/A
- CARE $14.34
- P/E Ratio
- TSHA N/A
- CARE $13.72
- Revenue Growth
- TSHA N/A
- CARE 18.52
- 52 Week Low
- TSHA $1.05
- CARE $11.96
- 52 Week High
- TSHA $4.32
- CARE $20.40
- Technical
- Relative Strength Index (RSI)
- TSHA 60.38
- CARE 63.86
- Support Level
- TSHA $2.44
- CARE $15.76
- Resistance Level
- TSHA $2.95
- CARE $16.56
- Average True Range (ATR)
- TSHA 0.25
- CARE 0.30
- MACD
- TSHA -0.02
- CARE 0.08
- Stochastic Oscillator
- TSHA 51.60
- CARE 90.19
About TSHA Taysha Gene Therapies Inc.
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.
About CARE Carter Bankshares Inc.
Carter Bankshares Inc is a bank holding company that conducts its business solely through the bank. The Bank earns revenue from interest on loans and securities and fees charged for financial services provided to customers. It offers a full range of deposit services including Lifetime Free Checking, interest checking accounts, savings accounts, retirement accounts and other deposit accounts of various types, ranging from money market accounts to longer-term CDs. The Bank offers a full range of commercial and consumer loans. The Bank also originates and holds fixed and variable-rate mortgage loans and offers home equity lines of credit to its customers.